IGF2 and colorectal carcinoma: Another study designed a conditionally replicative oncolytic adenovirus, Ad312-E1A, to target CRC cells with IGF2 imprinting (LOI) loss, a common epigenetic abnormality in CRC and other malignancies [49,50].